Proteomic Profiling of Plasma-Derived Biomarkers in Patients with Bladder Cancer: A Step towards Clinical Translation.
Taoufik NedjadiNada AlbarakatiAfshan MasoodAfshan MasoudAssim A AlfaddaJaudah Al-MaghrabiPublished in: Life (Basel, Switzerland) (2021)
Our findings provide additional insight into understanding bladder cancer pathogenesis. Our data identified potential non-invasive plasma-derived biomarker proteins that merit additional investigation to validate its clinical usefulness to prevent bladder cancer progression.